Drug Trial Radar · NCT03298945
Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens
Last checked: Nov 19, 2026Latest source record: Feb 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,239
Actual
Start
Dec 13, 2018
Primary completion
Dec 30, 2023
Study completion Jun 30, 2024
Sponsor
- Lead sponsor
- VA Office of Research and DevelopmentFederal agency
- Sponsor type
- Federal agency
- First posted
- Oct 2, 2017
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Health services research
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
From the patients' perspective, the most formidable part of the colonoscopy experience is the process of bowel cleansing. A poorly tolerated bowel preparation regimen often leads to incompletion of scheduled colonoscopies which in turn undermines the effectiveness of colonoscopy, increases cost, and decreases patient satisfaction. The current standard bowel preparation in the VA is of larger volume and less palatable than another commonly used bowel preparation regimen. The investigators propose to compare these two commonly used bowel preparations with respect to the overall completion rate of scheduled colonoscopies in a real-world VA practice setting. The results of the study can be immediately applied to maximize the effectiveness of colonoscopy and increase patient satisfaction in the VA.
Conditions
- Colorectal Cancer
Interventions
Miralax-Gatorade PrepDrug
2-L split-dose Miralax-Gatorade bowel prep for colonoscopy
GolytelyDrug
4-L split dose Golytely is the current standard prep at the VA
Primary outcomes
What the sponsor says the trial is designed to measure.
- Colonoscopy Completion RateTime frame: This outcome is determined within 1 month after colonoscopy
- Population Level Adenoma Detection Rate (ADR)Time frame: within 1 month of colonoscopy
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.